Literature DB >> 1593376

Intestinal permeability to 51Cr-EDTA and orocecal transit time in cystic fibrosis.

H Escobar1, M Perdomo, F Vasconez, C Camarero, M T del Olmo, L Suárez.   

Abstract

Intestinal permeability was investigated in 16 children with cystic fibrosis and 14 age-matched controls, making use of 51Cr-EDTA as probe molecule. Orocecal transit time was also evaluated using the lactulose/hydrogen breath test. There was an increase in permeability to 51Cr-EDTA in patients with cystic fibrosis (mean 13.62%) compared with the control group (mean 1.08%). The orocecal transit time was prolonged in patients with cystic fibrosis compared with controls. Mean fasting breath hydrogen concentration was significantly greater in cystic fibrosis patients (13 ppm) compared with control patients (3 ppm). There was no correlation between the percentage of 51Cr-EDTA excreted and the orocecal transit time in either control or cystic fibrosis patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1593376     DOI: 10.1097/00005176-199202000-00015

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

Review 1.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse.

Authors:  Robert C De Lisle; Racquel Mueller; Megan Boyd
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-10       Impact factor: 2.839

3.  Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine.

Authors:  Oxana Norkina; Tim G Burnett; Robert C De Lisle
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine.

Authors:  R C de Lisle; R Sewell; L Meldi
Journal:  Neurogastroenterol Motil       Date:  2009-10-08       Impact factor: 3.598

Review 5.  The cystic fibrosis intestine.

Authors:  Robert C De Lisle; Drucy Borowitz
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 6.  Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation.

Authors:  Hubert P J van der Doef; Freddy T M Kokke; Cornelis K van der Ent; Roderick H J Houwen
Journal:  Curr Gastroenterol Rep       Date:  2011-06

7.  Effect of liver transplantation on intestinal permeability and correlation with infection episodes.

Authors:  Francesca Romana Ponziani; Venanzio Valenza; Erida Nure; Giuseppe Bianco; Giuseppe Marrone; Antonio Grieco; Maurizio Pompili; Antonio Gasbarrini; Salvatore Agnes; Gabriele Sganga
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

8.  Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse.

Authors:  Robert C De Lisle; Lauren Meldi; Eileen Roach; Maureen Flynn; Racquel Sewell
Journal:  PLoS One       Date:  2009-01-27       Impact factor: 3.240

9.  Helminths as an alternative therapy for intestinal diseases.

Authors:  Aytan Miranda Sipahi; Daniel Machado Baptista
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.